{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:46:40Z","timestamp":1769161600177,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ab.2019.113475","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T11:58:11Z","timestamp":1571399891000},"page":"113475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography:Application in TDM"],"prefix":"10.1016","volume":"588","author":[{"given":"Xurui","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuran","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2019.113475_bib1","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1111\/epi.12952","article-title":"Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis","volume":"56","author":"Zighetti","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.ab.2019.113475_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2005.04.010","article-title":"The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview","volume":"7","author":"Ferraro","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ab.2019.113475_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ab.2019.113475_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/clpt.1985.116","article-title":"Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults","volume":"37","author":"Bauer","year":"1985","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.ab.2019.113475_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007691-199202000-00009","article-title":"Binding parameters of valproic acid to serum protein in healthy adults at steady state","volume":"14","author":"Kodama","year":"1992","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ab.2019.113475_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0021-9673(86)80018-8","article-title":"High-performance liquid chromatographic determination of valproic acid in plasma using a micelle-mediated pre-column derivatization","volume":"456","author":"van der Horst","year":"1988","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ab.2019.113475_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/jccs.201700397","article-title":"An electromembrane extraction-HPLC-UV analysis for the determination of valproic acid in human plasma","volume":"65","author":"Yaripour","year":"2018","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.ab.2019.113475_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jps.2600730734","article-title":"Rapid gas chromatographic assay for monitoring valproic acid and valpromide in plasma","volume":"73","author":"Bialer","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ab.2019.113475_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ab.2019.113475_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/FTD.0000000000000431","article-title":"Development of a simple and rapid method to measure free fraction of valproic acid in plasma using ultrafiltration and ultra high performance liquid chromatography-mass spectroscopy: application to therapeutic drug monitoring","volume":"39","author":"Xu","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ab.2019.113475_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.1983.tb02179.x","article-title":"Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing","volume":"16","author":"Rapeport","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ab.2019.113475_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/phar.1965","article-title":"Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia","volume":"37","author":"Dore","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ab.2019.113475_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1345\/aph.19147","article-title":"Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia","volume":"34","author":"Haroldson","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ab.2019.113475_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.2042-7158.2011.01282.x","article-title":"No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy","volume":"63","author":"Suzuki","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ab.2019.113475_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/FTD.0000000000000225","article-title":"The influence of plasma albumin concentration on the analysis methodology of free valproic acid by ultrafiltration and its application to therapeutic drug monitoring","volume":"37","author":"Zhang","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ab.2019.113475_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.seizure.2014.10.010","article-title":"Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy","volume":"25","author":"Dwivedi","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.ab.2019.113475_bib17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1515\/CCLM.2004.245","article-title":"Therapeutic drug monitoring of old and newer anti-epileptic drugs","volume":"42","author":"Neels","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ab.2019.113475_bib18","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bmc.2726","article-title":"Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring","volume":"26","author":"Shibata","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ab.2019.113475_bib19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/clinchem\/25.7.1303","article-title":"Gas-chromatographic analysis for valproic acid as phenacyl esters","volume":"25","author":"Gupta","year":"1979","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ab.2019.113475_bib20","first-page":"61","article-title":"A rapid and simple procedure for monitoring valproic acid by gas chromatography","volume":"90","author":"Mostafa","year":"2017","journal-title":"J. Biol. Res. Boll. - Soc. Ital. Biol. Sper."},{"key":"10.1016\/j.ab.2019.113475_bib21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.seizure.2007.12.007","article-title":"Value of therapeutic drug level monitoring and unbound (free) levels","volume":"17","author":"Chan","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.ab.2019.113475_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00007691-199302000-00005","article-title":"Free phenytoin monitoring in serum and saliva of epileptic patients in China","volume":"15","author":"Cai","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ab.2019.113475_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00007691-198306000-00007","article-title":"Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients","volume":"5","author":"Riva","year":"1983","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ab.2019.113475_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2125.1989.tb03548.x","article-title":"Morphine metabolism in children","volume":"28","author":"Choonara","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ab.2019.113475_bib25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/dmd.110.037192","article-title":"The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver","volume":"39","author":"Miyagi","year":"2011","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.ab.2019.113475_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2146\/ajhp140191","article-title":"Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients","volume":"72","author":"Gibbs","year":"2015","journal-title":"Am. J. Health Syst. Pharm. Off. J. Am. Soc. Health Syst. Pharm."},{"key":"10.1016\/j.ab.2019.113475_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007691-199210000-00006","article-title":"Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine","volume":"14","author":"Battino","year":"1992","journal-title":"Ther. Drug Monit."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269719306220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269719306220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:28:23Z","timestamp":1757712503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269719306220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":27,"alternative-id":["S0003269719306220"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2019.113475","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography:Application in TDM","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2019.113475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113475"}}